Endocrine Therapy in Breast Cancer
- Publisher's listprice GBP 107.00
-
51 119 Ft (48 685 Ft + 5% VAT)
The price is estimated because at the time of ordering we do not know what conversion rates will apply to HUF / product currency when the book arrives. In case HUF is weaker, the price increases slightly, in case HUF is stronger, the price goes lower slightly.
- Discount 10% (cc. 5 112 Ft off)
- Discounted price 46 007 Ft (43 817 Ft + 5% VAT)
Subcribe now and take benefit of a favourable price.
Subscribe
51 119 Ft
Availability
Out of print
Why don't you give exact delivery time?
Delivery time is estimated on our previous experiences. We give estimations only, because we order from outside Hungary, and the delivery time mainly depends on how quickly the publisher supplies the book. Faster or slower deliveries both happen, but we do our best to supply as quickly as possible.
Product details:
- Edition number 1
- Publisher CRC Press
- Date of Publication 8 March 2002
- ISBN 9780824707873
- Binding Hardback
- No. of pages400 pages
- Size 254x177 mm
- Weight 658 g
- Language English 0
Categories
Short description:
Jan G. M. Klijn, Els M. J. J. Berns, and John A. Foekens
Panel Discussion 1: Advanced Breast Cancer
Manfred Kaufmann and Henning T. Mouridsen
Early Breast Cancer
Early Breast Cancer: Tamoxifen Overview
Carsten Rose
Aromatase Inhibitors and Early Breast Cancer
Paul E. Goss
SERMs: Overview in Early Breast Cancer
Ian E. Smith
Surrogate and Intermediate Markers in Early Breast Cancer
Mitch Dowsett
Panel Discussion 2: Early Breast Cancer
Hans-Jorg Senn and William R. Miller
Neoadjuvant Therapy
Neoadjuvant Endocrine Therapy for Breast Cancer: A Medical Oncologist's Perspective
Matthew J. Ellis
Neoadjuvant Therapy: Surgical Perspectives
J. Michael Dixon
Pathology of Breast Cancer Following Neoadjuvant Endocrine Therapy
Hironobu Sasano, Takashi Suzuki, and Takuya Moriya
Neoadjuvant Therapy: Prediction of Response
William R. Miller, T. J. Anderson, S. Iqbal, and J. Michael Dixon
Mechanisms of Resistance to Endocrine Therapy
Nancy E. Hynes
Panel Discussion 3: Neoadjuvant Therapy
James N. Ingle and Ian E. Smith
Chemoprevention
Epidemiological Basis of Hormonal Chemoprevention of Breast Cancer
Malcolm C. Pike, John R. Daniels, and Darcy V. Spicer
Breast Carcinogenesis and Its Prevention by Inhibition of Estrogen Genotoxicity
Joachim G. Liehr
Use of Selective Antiestrogens for the Chemoprevention of Breast Cancer
Trevor J. Powles
Aromatase Inhibitors and Chemoprevention of Breast Cancer
Paul E. Goss
Panel Discussion 4: Chemoprevention
Christopher C. Benz and Anthony Howell
Conclusion
Panel Discussion 5: Final Discussion and Wrap-Up
James N. Ingle and Ajay Bhatnagar
Index
This reference evaluates and describes the latest strategies for hormone suppression and blockade in the management of early and advanced stage breast cancer and explores the effects of tamoxifen, selective estrogen receptor modulators (SERMs), aromatase inhibitors, and their combination on both breast cancers and normal tissues.
Endocrine Therapy in Breast Cancer
Surveying the medical, surgical, and pathological aspects of endocrine therapy, as well as future research opportunities, Endocrine Therapy in Breast Cancer is a concise and in-depth manual for medical, surgical, and radiation oncologists; endocrinologists; gynecologists; obstetricians; pharmacologists; family physicians; reproductive biologists; epidemiologists; and medical school students.
Long description:
This reference evaluates and describes the latest strategies for hormone suppression and blockade in the management of early and advanced stage breast cancer and explores the effects of tamoxifen, selective estrogen receptor modulators (SERMs), aromatase inhibitors, and their combination on both breast cancers and normal tissues.
Endocrine Therapy in Breast Cancer
Surveying the medical, surgical, and pathological aspects of endocrine therapy, as well as future research opportunities, Endocrine Therapy in Breast Cancer is a concise and in-depth manual for medical, surgical, and radiation oncologists; endocrinologists; gynecologists; obstetricians; pharmacologists; family physicians; reproductive biologists; epidemiologists; and medical school students.
This reference evaluates and describes the latest strategies for hormone suppression and blockade in the management of early and advanced stage breast cancer and explores the effects of tamoxifen, selective estrogen receptor modulators (SERMs), aromatase inhibitors, and their combination on both breast cancers and normal tissues.
Endocrine Therapy in Breast Cancer
Surveying the medical, surgical, and pathological aspects of endocrine therapy, as well as future research opportunities, Endocrine Therapy in Breast Cancer is a concise and in-depth manual for medical, surgical, and radiation oncologists; endocrinologists; gynecologists; obstetricians; pharmacologists; family physicians; reproductive biologists; epidemiologists; and medical school students.
Table of Contents:
Introduction
Why Endocrine Therapy?
Daniel F. Hayes
Advanced Breast Cancer
Tamoxifen and Advanced Breast Cancer: An Overview
John F. Forbes
Overview of Aromatase Inhibitors and Inactivators in the Treatment of Advanced Breast Cancer
Per Eystein Lonning
Endocrine Treatment of Advanced Breast Cancer-Selective Estrogen-Receptor Modulators (SERMs)
Stephen R. D. Johnston and Anthony Howell
Other Endocrine and Biological Agents in the Treatment of Advanced Breast Cancer
